Filing Details

Accession Number:
0001209191-23-012015
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-22 20:25:50
Reporting Period:
2023-02-22
Accepted Time:
2023-02-22 20:25:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1672619 Imara Inc. IMRA Pharmaceutical Preparations (2834) 811523849
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1805097 D. Rahul Ballal C/O Imara Inc.
116 Huntington Avenue, 6Th Floor
Boston MA 02116
Chief Executive Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-02-22 32,861 $4.66 87,835 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.